首页> 外文期刊>American Journal of Physiology >Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
【24h】

Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.

机译:通过降低 F26P2 水平来扰动肝脏中的葡萄糖通量会导致肝脏胰岛素抵抗和高血糖。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hepatic insulin resistance is one of the characteristics of type 2 diabetes and contributes to the development of hyperglycemia. How changes in hepatic glucose flux lead to insulin resistance is not clearly defined. We determined the effects of decreasing the levels of hepatic fructose 2,6-bisphosphate (F26P(2)), a key regulator of glucose metabolism, on hepatic glucose flux in the normal 129J mice. Upon adenoviral overexpression of a kinase activity-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, the enzyme that determines F26P(2) level, hepatic F26P(2) levels were decreased twofold compared with those of control virus-treated mice in basal state. In addition, under hyperinsulinemic conditions, hepatic F26P(2) levels were much lower than those of the control. The decrease in F26P(2) leads to the elevation of basal and insulin-suppressed hepatic glucose production. Also, the efficiency of insulin to suppress hepatic glucose production was decreased (63.3 vs. 95.5 suppression of the control). At the molecular level, a decrease in insulin-stimulated Akt phosphorylation was consistent with hepatic insulin resistance. In the low hepatic F26P(2) states, increases in both gluconeogenesis and glycogenolysis in the liver are responsible for elevations of hepatic glucose production and thereby contribute to the development of hyperglycemia. Additionally, the increased hepatic gluconeogenesis was associated with the elevated mRNA levels of peroxisome proliferator-activated receptor-gamma coactivator-1alpha and phosphoenolpyruvate carboxykinase. This study provides the first in vivo demonstration showing that decreasing hepatic F26P(2) levels leads to increased gluconeogenesis in the liver. Taken together, the present study demonstrates that perturbation of glucose flux in the liver plays a predominant role in the development of a diabetic phenotype, as characterized by hepatic insulin resistance.
机译:肝胰岛素抵抗是2型糖尿病的特征之一,有助于高血糖症的发展。肝葡萄糖通量的变化如何导致胰岛素抵抗尚不清楚。我们确定了降低肝脏果糖 2,6-二磷酸 (F26P(2)) 水平(葡萄糖代谢的关键调节剂)对正常 129J 小鼠肝葡萄糖通量的影响。在腺病毒过表达激酶活性缺陷的 6-磷酸果糖-2-激酶/果糖-2,6-双磷酸酶(决定 F26P(2) 水平的酶)时,肝脏 F26P(2) 水平与对照病毒处理的小鼠相比降低了两倍在基础状态。此外,在高胰岛素血症条件下,肝脏F26P(2)水平远低于对照组。F26P(2)的降低导致基础和胰岛素抑制的肝葡萄糖产生升高。此外,胰岛素抑制肝脏葡萄糖产生的效率降低(63.3% vs. 95.5% 抑制对照组)。在分子水平上,胰岛素刺激的Akt磷酸化的减少与肝脏胰岛素抵抗一致。在低肝F26P(2)状态下,肝脏中糖异生和糖原分解的增加是肝脏葡萄糖产生升高的原因,从而有助于高血糖症的发展。此外,肝糖异生增加与过氧化物酶体增殖物激活受体-γ 共激活因子-1α 和磷酸烯醇丙酮酸羧激酶的 mRNA 水平升高有关。这项研究提供了第一个体内证明,表明肝脏 F26P(2) 水平降低会导致肝脏糖异生增加。综上所述,本研究表明,肝脏中葡萄糖通量的扰动在糖尿病表型的发展中起着主要作用,其特征是肝脏胰岛素抵抗。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号